{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:55:48Z","timestamp":1760316948462,"version":"build-2065373602"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.schres.2024.02.019","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T16:30:56Z","timestamp":1709137856000},"page":"197-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Symptomatic remission and recovery in major psychosis: Is there a role for BDNF? A secondary analysis of the LABSP cohort data"],"prefix":"10.1016","volume":"266","author":[{"given":"Ulker","family":"Isayeva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirko","family":"Manchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Collu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Primavera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Deriu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Caboni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Novella Maria","family":"Iaselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Sundas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Tusconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Pinna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Paribello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Scherma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Pisanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Meloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clement C.","family":"Zai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donatella","family":"Congiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio","family":"Squassina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Fratta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Fadda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardo","family":"Carpiniello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2024.02.019_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2014.12.069","article-title":"Brain-derived neurotrophic factor (BDNF) and neurocognitive deficits in people with schizophrenia: a meta-analysis","volume":"226","author":"Ahmed","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2024.02.019_bb0010","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/10673229.2012.747804","article-title":"Remission in schizophrenia: critical and systematic review","volume":"20","author":"AlAqeel","year":"2013","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.schres.2024.02.019_bb0015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"AJP"},{"key":"10.1016\/j.schres.2024.02.019_bb0020","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.mp.4001637","article-title":"BDNF in schizophrenia, depression and corresponding animal models","volume":"10","author":"Angelucci","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2024.02.019_bb0025","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.schres.2024.02.019_bb0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/08977190410001723308","article-title":"Brain-derived neurotrophic factor","volume":"22","author":"BINDER","year":"2004","journal-title":"Growth Factors"},{"key":"10.1016\/j.schres.2024.02.019_bb0035","first-page":"2125","article-title":"Employment and the associated impact on quality of life in people diagnosed with schizophrenia","volume":"11","author":"Bouwmans","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.schres.2024.02.019_bb0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pneurobio.2005.06.003","article-title":"BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis","volume":"76","author":"Bramham","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.schres.2024.02.019_bb0045","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/schbul\/8.3.470","article-title":"Measurement of premorbid adjustment in chronic schizophrenia","volume":"8","author":"Cannon-Spoor","year":"1982","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2024.02.019_bb0050","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.3390\/jcm11133840","article-title":"Latent profiles of premorbid adjustment in schizophrenia and their correlation with measures of recovery","volume":"11","author":"Caqueo-Ur\u00edzar","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.schres.2024.02.019_bb0055","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jpsychires.2010.06.012","article-title":"Low serum truncated-BDNF isoform correlates with higher cognitive impairment in schizophrenia","volume":"45","author":"Carlino","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2024.02.019_bb0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1176\/jnp.2009.21.1.30","article-title":"Brain-derived neurotrophic factor Val66Met polymorphism: association with psychopathological symptoms of schizophrenia?","volume":"21","author":"Chang","year":"2009","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.schres.2024.02.019_bb0065","article-title":"Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London","volume":"6","author":"Chang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.schres.2024.02.019_bb0070","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00213-009-1665-6","article-title":"Decreased levels of serum brain-derived neurotrophic factor in drug-na\u00efve first-episode schizophrenia: relationship to clinical phenotypes","volume":"207","author":"Chen","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2024.02.019_bb0075","doi-asserted-by":"crossref","first-page":"16481","DOI":"10.1073\/pnas.0902833106","article-title":"Dendritic trafficking of BDNF mRNA is mediated by translin and blocked by the G196A (Val66Met) mutation","volume":"106","author":"Chiaruttini","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"year":"1988","series-title":"Il sistema AMDP. Manuale per la valutazione e la Documentazione della Psicopatologia","author":"Conti","key":"10.1016\/j.schres.2024.02.019_bb0080"},{"key":"10.1016\/j.schres.2024.02.019_bb0085","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.15032su1","article-title":"The use of long-acting injectable antipsychotics in schizophrenia: evaluating the evidence","volume":"77","author":"Correll","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2024.02.019_bb0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/03007995.2020.1841618","article-title":"The burden of disease in early schizophrenia \u2013 a systematic literature review","volume":"37","author":"Crespo-Facorro","year":"2021","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.schres.2024.02.019_bb0095","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0092-8674(03)00035-7","article-title":"The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function","volume":"112","author":"Egan","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.schres.2024.02.019_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109673","article-title":"Depressive symptoms in schizophrenia patients: a possible relationship between SIRT1 and BDNF","volume":"95","author":"Fang","year":"2019","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2024.02.019_bb0105","article-title":"Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications","volume":"12","author":"Fernandes","year":"2015","journal-title":"Mol. Psychiatry"},{"year":"1997","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders","author":"FIRST","key":"10.1016\/j.schres.2024.02.019_bb0110"},{"key":"10.1016\/j.schres.2024.02.019_bb0115","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.schres.2023.01.007","article-title":"Schizophrenia or schizoaffective disorder? A 50-year assessment of diagnostic stability based on a national case registry","volume":"252","author":"Florentin","year":"2023","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2024.02.019_bb0120","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1038\/npp.2010.111","article-title":"Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable vs quetiapine: results of a long-term, open-label, randomized clinical trial","volume":"35","author":"Gaebel","year":"2010","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.schres.2024.02.019_bb0125","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1471-244X-13-58","article-title":"Attitudes towards the administration of long-acting antipsychotics: a survey of physicians and nurses","volume":"13","author":"Geerts","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2024.02.019_bb0130","series-title":"Recovery and Major Mental Disorders","first-page":"23","article-title":"Determinants of clinical recovery in schizophrenia","author":"Giordano","year":"2022"},{"key":"10.1016\/j.schres.2024.02.019_bb0135","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1176\/ajp.149.9.1148","article-title":"Revising axis V for DSM-IV: a review of measures of social functioning","volume":"149","author":"Goldman","year":"1992","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2024.02.019_bb0140","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2004.09.009","article-title":"Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS","volume":"72","author":"Green","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2024.02.019_bb0145","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/mp.2010.88","article-title":"Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis","volume":"16","author":"Green","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2024.02.019_bb0150","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1360-0443.2008.02435.x","article-title":"Modeling mood variation associated with smoking: an application of a heterogeneous mixed-effects model for analysis of ecological momentary assessment (EMA) data","volume":"104","author":"Hedeker","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.schres.2024.02.019_bb0155","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jpsychires.2005.11.004","article-title":"Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients","volume":"40","author":"Huang","year":"2006","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2024.02.019_bb0160","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0092-8674(00)81509-3","article-title":"BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex","volume":"98","author":"Huang","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.schres.2024.02.019_bb0165","article-title":"Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients","volume":"65","author":"Isayeva","year":"2022","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.schres.2024.02.019_bb0170","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1176\/appi.ajp.2009.07081221","article-title":"Olanzapine long-acting injection: a 24-week, randomized, double-blind trial of maintenance treatment in patients with schizophrenia","volume":"167","author":"Kane","year":"2010","journal-title":"AJP"},{"key":"10.1016\/j.schres.2024.02.019_bb0175","article-title":"BDNF Val66Met polymorphism is associated with negative symptoms in early-onset schizophrenia spectrum and other psychotic disorders","author":"Karacetin","year":"2021","journal-title":"Eur. J. Psychiatry"},{"key":"10.1016\/j.schres.2024.02.019_bb0180","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2024.02.019_bb0185","article-title":"BDNF: a key factor with multipotent impact on brain signaling and synaptic plasticity","volume":"15","author":"Kowia\u0144ski","year":"2018","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.schres.2024.02.019_bb0190","doi-asserted-by":"crossref","first-page":"393","DOI":"10.31887\/DCNS.2010.12.3\/mlambert","article-title":"Remission in schizophrenia: validity, frequency, predictors, and patients\u2019 perspective 5 years later","volume":"12","author":"Lambert","year":"2010","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.schres.2024.02.019_bb0195","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s12031-012-9750-4","article-title":"Association between BDNF Val66Met polymorphism and cognitive performance in antipsychotic-naive patients with schizophrenia","volume":"47","author":"Lu","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.schres.2024.02.019_bb0200","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1600-0447.2007.01134.x","article-title":"Premorbid adjustment, symptom development and quality of life in first episode psychosis: a systematic review and critical reappraisal","volume":"117","author":"MacBeth","year":"2008","journal-title":"Acta Psychiatr. Scand."},{"year":"2018","series-title":"The Impact of Depot and Long Acting Injectable Antipsychotics on Serum Levels of Brain-derived Neurotrophic Factor in Schizophrenic and Schizoaffective Patients: Results of a 24-month Longitudinal Prospective Study","author":"Manchia","key":"10.1016\/j.schres.2024.02.019_bb0205"},{"key":"10.1016\/j.schres.2024.02.019_bb0210","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.3390\/brainsci12121666","article-title":"Converging evidence points to BDNF as biomarker of depressive symptoms in schizophrenia-spectrum disorders","volume":"12","author":"Manchia","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.schres.2024.02.019_bb0215","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.euroneuro.2022.02.003","article-title":"The role of BDNF and NGF plasma levels in first-episode schizophrenia: a longitudinal study","volume":"57","author":"Mart\u00ednez-Pinte\u00f1o","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2024.02.019_bb0220","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.schres.2017.01.047","article-title":"The course of negative symptoms in first-episode schizophrenia and its predictors: a prospective two-year follow-up study","volume":"189","author":"Mezquida","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2024.02.019_bb0225","first-page":"133","article-title":"A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables","volume":"10","author":"Naber","year":"1995","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2024.02.019_bb0230","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s12272-013-0105-7","article-title":"Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia","volume":"36","author":"Park","year":"2013","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.schres.2024.02.019_bb0235","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1185\/03007990903488670","article-title":"Treatment retention with risperidone long-acting injection: 24-month results from the Electronic Schizophrenia Treatment Adherence Registry (e-STAR) in six countries","volume":"26","author":"Peuskens","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.schres.2024.02.019_bb0240","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1017\/S1461145709991015","article-title":"Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology","volume":"13","author":"Pillai","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2024.02.019_bb0245","series-title":"Mixed-effects Models in S and S-Plus","first-page":"3","article-title":"Linear mixed-effects models: basic concepts and examples","author":"Pinheiro","year":"2000"},{"key":"10.1016\/j.schres.2024.02.019_bb0250","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-014938","article-title":"Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study","volume":"7","author":"Primavera","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.schres.2024.02.019_bb0255","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.psychres.2014.07.079","article-title":"Serum brain-derived neurotrophic factor (BDNF) and its association with remission status in Chinese patients with schizophrenia","volume":"220","author":"Renjan","year":"2014","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2024.02.019_bb0260","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1176\/appi.ps.55.5.540","article-title":"An exploratory analysis of correlates of recovery","volume":"55","author":"Resnick","year":"2004","journal-title":"PS"},{"key":"10.1016\/j.schres.2024.02.019_bb0265","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/15622970802182733","article-title":"Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics","volume":"11","author":"Rizos","year":"2010","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2024.02.019_bb0270","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jpsychires.2018.09.007","article-title":"The neurobiological hypothesis of neurotrophins in the pathophysiology of schizophrenia: a meta-analysis","volume":"106","author":"Rodrigues-Amorim","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2024.02.019_bb0275","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ajmg.b.30266","article-title":"The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with risk for psychosis: evidence from a family-based association study","volume":"141","author":"Rosa","year":"2006","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.schres.2024.02.019_bb0280","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1440-1819.2006.01462.x","article-title":"Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene","volume":"60","author":"Rybakowski","year":"2006","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2024.02.019_bb0285","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neulet.2003.08.004","article-title":"Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls","volume":"351","author":"Shimizu","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.schres.2024.02.019_bb0290","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/15622970410029936","article-title":"Association analysis of brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism in schizophrenia and bipolar affective disorder","volume":"5","author":"Skibinska","year":"2004","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2024.02.019_bb0295","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.psychres.2018.06.029","article-title":"Premorbid adjustment predictors of cognitive dysfunction in schizophrenia","volume":"267","author":"Stefanatou","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2024.02.019_bb0300","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/YPG.0b013e328360c866","article-title":"BDNF Val66Met polymorphism and anxiety\/depression symptoms in schizophrenia in a Chinese Han population","volume":"23","author":"Sun","year":"2013","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.schres.2024.02.019_bb0305","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.schres.2006.06.029","article-title":"No evidence for an association between the BDNF Val66Met polymorphism and schizophrenia or personality traits","volume":"87","author":"Tochigi","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2024.02.019_bb0310","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.schres.2017.08.032","article-title":"Targeting recovery in first episode psychosis: the importance of neurocognition and premorbid adjustment in a 3-year longitudinal study","volume":"195","author":"Treen Calvo","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2024.02.019_bb0315","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1600-0447.2005.00659.x","article-title":"Standardized remission criteria in schizophrenia","volume":"113","author":"Van Os","year":"2006","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2024.02.019_bb0320","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/YCO.0000000000000407","article-title":"Recovery from schizophrenia: is it possible?","volume":"31","author":"Vita","year":"2018","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.schres.2024.02.019_bb0325","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/08039488.2015.1087592","article-title":"Serum levels of brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) in depressed patients with schizophrenia","volume":"70","author":"Wysoki\u0144ski","year":"2016","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.schres.2024.02.019_bb0330","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.schres.2010.02.694","article-title":"Serum BDNF levels are determined by functional polymorphism VAL66MET and associated with cognitive impairment in chronic schizophrenia","volume":"2\u20133","author":"Xiu","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2024.02.019_bb0335","first-page":"1617","article-title":"Association of the brain-derived neurotrophic factor gene G196A rs6265 polymorphisms and the cognitive function and clinical symptoms of schizophrenia","volume":"6","author":"Zhai","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.schres.2024.02.019_bb0340","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00439-012-1150-x","article-title":"Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls","volume":"131","author":"Zhang","year":"2012","journal-title":"Hum. Genet."},{"key":"10.1016\/j.schres.2024.02.019_bb0345","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.schres.2013.01.020","article-title":"Genetic variation in BDNF is associated with antipsychotic treatment resistance in patients with schizophrenia","volume":"146","author":"Zhang","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2024.02.019_bb0350","series-title":"Progress in Neuro-psychopharmacology and Biological Psychiatry","first-page":"930","article-title":"The study of BDNF Val66Met polymorphism in Chinese schizophrenic patients","volume":"34","author":"Zhou","year":"2010"},{"key":"10.1016\/j.schres.2024.02.019_bb0355","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/schbul\/sbs135","article-title":"The myth of schizophrenia as a progressive brain disease","volume":"39","author":"Zipursky","year":"2013","journal-title":"Schizophr. Bull."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996424000550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996424000550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:57:08Z","timestamp":1760299028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996424000550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":71,"alternative-id":["S0920996424000550"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2024.02.019","relation":{},"ISSN":["0920-9964"],"issn-type":[{"type":"print","value":"0920-9964"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Symptomatic remission and recovery in major psychosis: Is there a role for BDNF? A secondary analysis of the LABSP cohort data","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2024.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}